Low-grade inflammation may moderate the effect of behavioral treatment for chronic pain in adults.
2016 (English)In: Journal of behavioral medicine, ISSN 0160-7715, E-ISSN 1573-3521, Vol. 39, no 5, 916-924 p.Article in journal (Refereed) Published
The purpose of the present pilot study was to explore the moderating role of basal inflammation on the effects of behavioral pain treatment in 41 patients with long-standing pain. Baseline pro-inflammatory status moderated behavioral treatment outcomes: higher pre-treatment levels of Tumor Necrosis Factor (TNF)-α and Interleukin (IL)-6 were related to less improvement in pain intensity, psychological inflexibility and in mental health-related quality of life. The treatment outcomes improved in the subgroup that had low levels of pro-inflammatory cytokines at baseline, while the subjects with higher pro-inflammatory status did not. Altogether, results indicate that low-grade inflammation may influence the behavioral treatment outcomes and provide a possible explanation of the heterogeneity in treatment response.
Place, publisher, year, edition, pages
2016. Vol. 39, no 5, 916-924 p.
Medical and Health Sciences
IdentifiersURN: urn:nbn:se:su:diva-133850DOI: 10.1007/s10865-016-9769-zPubMedID: 27469518Local ID: P-3360OAI: oai:DiVA.org:su-133850DiVA: diva2:971915